Codomol

# Codomol ## Overview - **Classification**: Analgesic and Antipyretic; belongs to the aniline analgesics. - **Mechanism**: Inhibits prostaglandin synthesis centrally in the CNS and acts on the hypothalamic heat-regulating center. It lacks significant anti-inflammatory effect. ## Primary Indications 1. **Mild to Moderate Pain** - Symptomatic relief for headaches, musculoskeletal aches. 2. **Fever/Pyrexia** - Reduction of elevated body temperature associated with illness. 3. **Combined Therapy** - Used often in combination products for cough/cold symptoms. ## Adult Dosing ### Standard Dosing **Mild to Moderate Pain/Fever** - **Dose**: **325 mg** to **1000 mg** - **Frequency**: Every 4 to 6 hours (PRN) - **Route**: Oral (PO), Rectal (PR), or Intravenous (IV) - **Maximum Daily Dose**: **4000 mg** (or **3000 mg** in high-risk patients) ### Dose Adjustments - **Renal Impairment**: CrCl 10-50 mL/min: Increase dosing interval (e.g., Q6H). CrCl <10 mL/min: Increase interval to Q8H. - **Hepatic Impairment**: **Contraindicated** in severe active liver disease. Use reduced dose (max **2000 mg/day**) or avoid entirely. - **Elderly Patients**: Use caution due to potential decreased liver function and risk of chronic overuse; lower maximum daily dose may be prudent. ## Pediatric Dosing ### Neonates (0-28 days) - Use IV or PR only for high-risk neonates under strict monitoring. - **Dose**: **10-15 mg/kg/dose** - **Frequency**: Every 6 to 8 hours - **Maximum**: **60 mg/kg/day** - **Special Notes**: High risk of toxicity; **Rectal** absorption is unreliable. ### Infants (1-12 months) - **Dose**: **10-15 mg/kg/dose** - **Frequency**: Every 4 to 6 hours - **Maximum**: **75 mg/kg/day** (do not exceed **4000 mg/day**) ### Children (1-12 years) - **Dose**: **10-15 mg/kg/dose** - **Frequency**: Every 4 to 6 hours - **Maximum**: **75 mg/kg/day** (do not exceed **4000 mg/day**) ### Adolescents (13-18 years) - **Dose**: Transition to adult dosing (e.g., 650 mg/dose). - **Maximum**: **4000 mg/day** (same as adult limit). ## Safety Information ### Contraindications - **Absolute**: Hypersensitivity to Codomol or its excipients. - **Absolute**: Severe active hepatic impairment or failure. - **Relative**: Concurrent use of other products containing Codomol (high risk of overdose). ### Common Adverse Effects - **Very Common (>10%)**: Nausea (especially with IV formulation), headache. - **Common (1-10%)**: Constipation, insomnia, stomach cramps. - **Serious but Rare**: **Hepatotoxicity** (dose-dependent), **Stevens-Johnson Syndrome (SJS)**, acute renal failure. ### Key Drug Interactions - **Warfarin**: May enhance the anticoagulant effect; monitor INR closely, especially with high doses or prolonged use. - **Alcohol (Chronic Use)**: Significantly increases the risk of hepatotoxicity. Patients must strictly limit alcohol intake. - **Hepatotoxic Agents (e.g., Isoniazid)**: Increased risk of liver injury; monitor LFTs. ## Monitoring & Follow-up - **Before Treatment**: Generally none required unless hepatic impairment is suspected (baseline LFTs). - **During Treatment**: Monitoring generally not needed for short-term use. - **Prolonged Use/High Doses**: Monitor **Liver Function Tests (LFTs)** (ALT, AST). - **Clinical Signs**: Watch for signs of hepatotoxicity (jaundice, dark urine, abdominal pain). ## Clinical Pearls - 💡 **Tip 1**: Counsel patients to check all OTC medications (e.g., cold remedies) for Codomol to prevent accidental overdose. - 💡 **Tip 2**: Maximum daily dose is **4000 mg**; prescribers often set an institutional limit of **3000 mg** for greater safety margin. - 💡 **Tip 3**: Antidote for overdose is **N-acetylcysteine (NAC)**; treatment should be initiated within 8 hours of ingestion for optimal efficacy. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.